Elevance Health (ELV) Enterprise Value (2009 - 2026)

Elevance Health (ELV) has 18 years of Enterprise Value data on file, last reported at -$35.8 billion in Q2 2026.

• On a quarterly basis, Enterprise Value fell 282.4% year-over-year to -$35.8 billion in Q2 2026; TTM through Jun 2026 was -$35.8 billion, a 282.4% decrease from a year earlier, with the FY2025 full-year figure at -$10.1 billion, down 7.66% from the prior year.
• Enterprise Value for Q2 2026 stood at -$35.8 billion, down from -$35.4 billion in the prior quarter.
• Over the last five years, Enterprise Value for ELV reached as high as -$6.6 billion in Q1 2024 and fell as low as -$35.8 billion in Q2 2026.
• Historically, Enterprise Value has averaged -$13.2 billion across 5 years, with a median of -$9.4 billion in 2024.
• Across the five-year window, Enterprise Value soared 77.03% in 2022 and tumbled 337.42% in 2026, its largest moves.
• Year by year, Enterprise Value stood at -$8.3 billion in 2022, then advanced by 19.35% to -$6.7 billion in 2023, then plunged by 40.76% to -$9.4 billion in 2024, then declined by 7.66% to -$10.1 billion in 2025, then plunged by 255.03% to -$35.8 billion in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were -$35.8 billion in Q2 2026, -$35.4 billion in Q1 2026, and -$10.1 billion in Q4 2025.